文献速递神经创伤神经重症

早期血小板减少与重症监护室治疗的创伤性脑损伤患者死亡风险增加相关:一项芬兰重症监护联盟研究

Early thrombocytopenia is associated with an increased risk of mortality in patients with traumatic brain injury treated in the intensive care unit: a Finnish Intensive Care Consortium study.
PubMed 文献 · Acta Neurochir (Wien) · 2022-07-15

这项回顾性多中心研究纳入2003—2019年收入ICU的成人创伤性脑损伤患者4419例,12%出现早期血小板减少(首日血小板计数<100×10⁹/L)。血小板减少组院内死亡率和12个月死亡率分别为26%和48%,血小板计数>100×10⁹/L组分别为9%和22%。在中重度TBI中,校正伤情严重程度后,血小板计数较高与院内死亡和12个月死亡风险降低相关;未输注血小板的血小板减少患者12个月死亡风险升高(OR 2.2,95%CI 1.6—3.0),而输注血小板者未见升高(OR 1.0,95%CI 0.6—1.7)。

要点

  • ICU治疗的TBI患者中约12%出现早期血小板减少。
  • 血小板减少组院内死亡率26%、12个月死亡率48%,均高于血小板计数>100×10⁹/L组的9%和22%。
  • 中重度TBI中,未输注血小板的血小板减少患者12个月死亡风险升高(OR 2.2)。

核心结论

  • 早期血小板减少见于约十分之一ICU治疗的TBI患者,是中重度TBI患者死亡的独立危险因素。
  • 进一步研究必要,以确定血小板输注能否改变这一风险。

研究设计与样本

  • 回顾性多中心研究,纳入2003—2019年收入ICU的成人TBI患者4419例。
  • 血小板减少定义为首日血小板计数<100×10⁹/L。
  • 采用多变量logistic回归分析血小板减少与院内死亡及12个月死亡的关联,并校正伤情严重程度指标。

主要发现

  • 4419例患者中530例(12%)存在早期血小板减少。
  • 血小板减少组院内死亡率为26%、12个月死亡率为48%;血小板计数>100×10⁹/L组分别为9%和22%。
  • 中重度TBI中,校正伤情严重程度后,血小板计数较高与院内死亡风险降低相关(每单位OR 0.998,95%CI 0.996—0.999)。
  • 中重度TBI中,校正伤情严重程度后,血小板计数较高与12个月死亡风险降低相关(每单位OR 0.998,95%CI 0.997—0.999)。
  • 与血小板计数正常者相比,未输注血小板的血小板减少患者12个月死亡风险升高(OR 2.2,95%CI 1.6—3.0)。

关键数值与推荐

  • 血小板减少定义:首日血小板计数<100×10⁹/L。
  • 院内死亡:血小板减少组26% vs 血小板计数>100×10⁹/L组9%。
  • 12个月死亡:血小板减少组48% vs 血小板计数>100×10⁹/L组22%。
  • 中重度TBI院内死亡:血小板计数每单位OR 0.998(95%CI 0.996—0.999)。
  • 中重度TBI 12个月死亡:血小板计数每单位OR 0.998(95%CI 0.997—0.999)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Coagulopathy after traumatic brain injury (TBI) is associated with poor prognosis. PURPOSE: To assess the prevalence and association with outcomes of early thrombocytopenia in patients with TBI treated in the intensive care unit (ICU). METHODS: This is a retrospective multicenter study of adult TBI patients admitted to ICUs during 2003-2019. Thrombocytopenia was defined as a platelet count < 100 × 109/L during the first day. The association between thrombocytopenia and hospital and 12-month mortality was tested using multivariable logistic regression, adjusting for markers of injury severity. RESULTS: Of 4419 patients, 530 (12%) had early thrombocytopenia. In patients with thrombocytopenia, hospital and 12-month mortality were 26% and 48%, respectively; in patients with a platelet count > 100 × 109/L, they were 9% and 22%, respectively. After adjusting for injury severity, a higher platelet count was associated with decreased odds of hospital mortality (OR 0.998 per unit, 95% CI 0.996-0.999) and 12-month mortality (OR 0.998 per unit, 95% CI 0.997-0.999) in patients with moderate-to-severe TBI. Compared to patients with a normal platelet count, patients with thrombocytopenia not receiving platelet transfusion had an increased risk of 12-month mortality (OR 2.2, 95% CI 1.6-3.0), whereas patients with thrombocytopenia receiving platelet transfusion did not (OR 1.0, 95% CI 0.6-1.7). CONCLUSION: Early thrombocytopenia occurs in approximately one-tenth of patients with TBI treated in the ICU, and it is an independent risk factor for mortality in patients with moderate-to-severe TBI. Further research is necessary to determine whether this is modifiable by platelet transfusion.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Lillemäe K, Luostarinen T, Reinikainen M, et al. Early thrombocytopenia is associated with an increased risk of mortality in patients with traumatic brain injury treated in the intensive care unit: a Finnish Intensive Care Consortium study. Acta Neurochir (Wien). 2022. PMID: 35838800. doi:10.1007/s00701-022-05277-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。